In multiple tumour contexts, low SHBG states are associated with increased c-Myc and Bcl-2 expression and activity, upregulation of glycolytic effectors GLUT1, LDH and HK2, promoting mitochondrial resistance to apoptosis. The gene discussed is MYC; the disease is neoplasm.